About Us

NEX-I, First-In-Class Cancer Immunotherapy Development Company

Leadership

  • KYOUNG WAN YOON

    CEO

    KYOUNG WAN YOON

    CEO
    • NEX-I / CEO
    • Genome & Company / CSO · EVP
    • Harvard Medical School & Massachusetts General Hospital / Research Fellow
    • Korea University / BS · MS · PhD
  • TAE WOO KIM

    CTO

    TAE WOO KIM

    CTO
    • NEX-I / CTO
    • Korea University College of Medicine / Professor
    • Johns Hopkins Medical School / Research Professor
    • KIST / Post-doc
    • Korea University / PhD
    • Kyungpook National University / BS · MS
  • JIN PUB SON

    COO

    JIN PUB SON

    COO
    • NEX-I / COO
    • Dong-A Socio Holdings / Strategic Investment manager
    • DM Bio / General Manager, Business Planning
    • Dong-A Socio Holdings / Research Planning & Clinical Research
    • Korea University / BS · MS · PhD
  • YOON SOO KANG

    CFO

    YOON SOO KANG

    CFO
    • NEX-I / CFO
    • ABION / CFO
    • Shinyoung Securities / Investment Banking
    • DB Financial Investment / Investment Banking
    • Ernst & Young / Advisory
    • Korea University / BS / Business Administration
  • EUNJU SHIN

    Head of Research

    EUNJU SHIN

    Head of Research
    • NEX-I / Head of Research
    • Genexine / Strategy planning Team leader
    • Genexine / Discovery Team leader
    • Ewha Womans University / PhD · Post-doc
  • TAE WAN KIM

    Head of Development

    TAE WAN KIM

    Head of Development
    • NEX-I / Head of Development
    • Hugel / Process Development
    • Dong-A ST Biotech / Antibody Development
    • GIST / MS
    • Pusan National University / BS
  • SOO HYEON KIM

    Head of Clinical Research

    SOO HYEON KIM

    Head of Clinical Research
    • NEX-I / Head of Clinical Research
    • Rznomics / Clinical Operation General Manager
    • Syneos Health / Senior Project Manager, Oncology
    • Korea Otsuka Pharmaceutical / Clinical Trial Manager, CRA
    • Hanmi Pharmaceutical / Product Manager
    • SNU College of Pharmacy / BS / Pharmacist
  • KYUNGJIN BOO

    Head of R&D Strategy

    KYUNGJIN BOO

    Head of R&D Strategy
    • NEX-I / Head of R&D Strategy
    • Max Planck Institutes / Post-doc
    • SNU Biological Sciences / BS · PhD · Post-doc
  • So Young Choi

    Director / Development Group

    So Young Choi

    Director / Development Group
    • NEX-I / Director, Development Group
    • Genexine / Director, CLD Team
    • POSTECH / Researcher
    • University of Ulsan / BS · MS
  • JEONGMIN RYOO

    Lead Scientist

    JEONGMIN RYOO

    Lead Scientist
    • NEX-I / Lead Scientist, Research Group
    • Albert-Ludwigs-Universität Freiburg / Post-doc
    • SNU Biological Sciences / BS · PhD · Post-doc
  • Hyung Gun Maeng

    Lead Scientist

    Hyung Gun Maeng

    Lead Scientist
    • NEX-I / Lead Scientist, Research Group
    • Seoul SongDo colorectal hospital, Immuno-biology Lab / Principal researcher
    • ILAb_/ New drug development team leader
    • SNU of medicine, immunology / PhD
    • Catholic University of medicine, medical bioscience / MS
    • Catholic University / BS
  • YOONJEONG KIM

    Lead Scientist

    YOONJEONG KIM

    Lead Scientist
    • NEX-I / Lead Scientist, Development Group
    • HK inno.N Corp.(formerly CJ Healthcare)/ Principal Researcher
    • HanAll Biopharma / Senior Researcher
    • Kyungpook National University / MS
  • JAYJAY JANG

    Director / Business Development

    JAYJAY JANG

    Director / Business Development
    • NEX-I / Director, Business Development
    • SN BioScience / Clinical Research & Business Development
    • Hanmi Pharmaceutical / Clinical Research & Business Development
    • University of Wisconsin – Madison / BS